Clinical trials have shown that higher endogenous RLN1 levels are present in patients with HF, but these elevated levels proved to be not enough to compensate the above mentioned pathologic mechanisms (Gu et al., 2012). This evidence concerns the gene RLN1 and hydrops fetalis.